Skip to content

The comparative effect of intravenous midazolam and sufentanyl on shivering in cesarean delivery

The comparative effect of intravenous midazolam and sufentanyl on shivering in cesarean delivery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201407191936N13
Enrollment
300
Registered
2014-08-03
Start date
2014-08-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shivering after spinal anesthesia.

Interventions

Intervention 1: In control group patient receive 2 milliliter of sterile water as placebo after delivery of fetus. Intervention 2: In intervention group 1 patient receive 0/02 mg per kg Midazolam plu
Treatment - Drugs
In control group patient receive 2 milliliter of sterile water as placebo after delivery of fetus
In intervention group 1 patient receive 0/02 mg per kg Midazolam plus strile water up to two milliliter after delivery of fetus
In intervention group 2 patients receive 0/1 mcg per kg Sufentanyl plus strile water up to two milliliter after delivery of fetus

Sponsors

Research Committee Bushehr University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: all women age between 15 and 45 years old who are candidates for caesarean section and signed informed consent are eligible to join the study. Exclusion criteria: any contra indication for R/A and those who are sensitive to midazolam or sufentanyl.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Shivering after cesarian delivery. Timepoint: Minutes 15, 30 and 60. Method of measurement: Observation.

Secondary

MeasureTime frame
Patients satisfaction. Timepoint: Before discharge. Method of measurement: Question.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Abdolreza Najafi Anaraki

Bushehr University of Medical Sciences

dr.najafianaraki@gmail.com+98 77 1354 0088

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026